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PURPOSE: To search for anti-retina antibodies that serve as markers for eye disease in uveitis.
MATERIALS AND METHODS: Stored sera from patients with uveitis, ocular toxoplasmosis (n = 30) and non-infectious,
immune-mediated uveitis (n = 50) and from asymptomatic individuals who were positive (n = 250) and negative
(n = 250) for anti-Toxoplasma antibodies were tested. Serum anti-retina IgG was detected by an optimized ELISA
using a solid-phase whole human retina extract, bovine S-antigen or interphotoreceptor retinoid-binding protein.
RESULTS: Uveitis patients showed a higher mean reactivity to whole human retina extract, interphotoreceptor
retinoid-binding protein and S-antigen in comparison to the asymptomatic population. These findings were
independent of the uveitis origin and allowed the determination of the lower anti-retina antibody cut-off for the
three antigens. Asymptomatic anti-Toxoplasma serum-positive individuals showed a higher frequency of anti-
human whole retina extract antibodies in comparison to asymptomatic anti-Toxoplasma serum-negative patients.
The bovine S-antigen and interphotoreceptor retinoid-binding protein ELISAs also showed a higher mean reactivity
in the uveitis groups compared to the asymptomatic group, but the observed reactivities were lower and
overlapped without discrimination.
CONCLUSION: We detected higher levels of anti-retina antibodies in uveitis patients and in a small fraction of
asymptomatic patients with chronic toxoplasmosis. The presence of anti-retina antibodies in sera might be a marker
of eye disease in asymptomatic patients, especially when whole human retina extract is used in a solid-phase ELISA.
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INTRODUCTION
Individuals with uveitis may present with visual loss
depending on the location of the site of inflammation.1 The
most prominent feature of uveitis is the inflammatory
process, which is characterized by an intraocular immune
response with several infectious and non-infectious etiolo-
gies.2 Most of the physiopathological studies of uveitis have
focused on the antigens that trigger the inflammatory
process, which can be an autoimmune response to retina
proteins3 or an infectious agent.1
Two bilateral granulomatous uveitis conditions, sympa-
thetic ophthalmia (SO) and Vogt-Koyanagi-Harada (VKH)
disease, share several clinical, histological and immunohis-
tochemical features despite exhibiting diverse triggering
events.4 In these two uveitis conditions, HLA-DR4 and
T-cell responses are associated with retina antigens, which
indicates the presence of an underlying T-cell-mediated
autoimmunity to uveal/retinal antigens during their
development.3,4 The only reported reliable feature that
could differentiate SO from VHK disease is a history of a
penetrating wound in SO and the absence of such trauma in
VKH disease. The intraocular compartment lacks lymphatic
drainage system and appears to function similarly to a
number of alymphatic biological sites that present altera-
tions in immune functions and antigen presentation.5 In an
SO experimental model, a subconjunctival injection of retina
S-antigen in one eye induced a bilateral sympathetic uveitis,
whereas an intraocular injection in one eye did not induce
disease.6 However, autoimmune antibodies against the
outer segments of photoreceptors and Muller cells have
been detected in patients with VKH disease, in some
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patients with Behcet’s syndrome, and in a few patients with
sympathetic ophthalmia.7 These results suggest that retina
autoimmunity may play an important role in the pathogen-
esis of posterior uveitis and that anti-retina antibodies are
present in this condition.
Toxoplasma gondii, which is a successful obligate intra-
cellular protozoan parasite, is widely distributed through-
out the world and infects more than two billion people
worldwide.8 Toxoplasma infection is usually asymptomatic
in humans, and persistent infection with the cyst form of
this parasite is controlled by the host immune system.
However, in fetuses and immunosuppressed patients (such
as AIDS patients or organ transplant recipients), the parasite
becomes activated and causes life-threatening disease.9 A
specific retina involvement may be present in up to 20% of
all Toxoplasma infected individuals, regardless of their
immune status.10 Toxoplasmosis is the most frequent cause
of posterior uveitis in the USA and Brazil, and it is
associated with visual impairment and blindness. The
diagnosis is usually based on characteristic fundoscopy
findings and the clinical presentation; the disease is usually
progressive and recurrent, and it can cause severe morbid-
ity. These outcomes occur despite the availability of an
effective treatment based on pyrimethamine, which is an
anti-parasitic drug that is associated with anti-inflammatory
drugs such as corticosteroids.11 In the eye, the primary
target tissue for ocular toxoplasmosis is the neural retina,
which displays a surrounding, intense granulomatous
reaction with numerous intracellular parasite cysts.12 Free
tachyzoites and cysts are also observed within retina pig-
ment epithelium (RPE) cells.13 Ocular reactions also involve
necrosis of the retina and RPE, subretinal and choroidal
neovascularization, and focal inflammation.14 The inflam-
matory processes that are associated with retina infection by
T. gondii may damage Bruch’s membrane, which results in a
disruption of the choroidoretinal interface.4
Toxoplasma uveitis can present the same autoimmune
response as SO and VKH: a disruption of the parasite cysts
that exposes the retina antigens. When central vision is
threatened, ocular toxoplasmosis is treated with specific
antibiotics together with corticosteroids, which suggests
that the host immune response plays an active role in the
disease process. In ocular toxoplasmosis, the involvement of
the eye and inadequate autoimmune responses of memory
cells to retina antigens in the blood have been reported
previously,10,14 but few studies have reported a high
frequency of retina autoantibodies titers in this condi-
tion.15,16 Furthermore, another group detected robust levels
of cellular responses against retina antigens in the blood
of ocular toxoplasmosis patients10. Alternatively, cross-
reactive antigens could be encoded and produced by the
infectious agent, which could induce autoimmunity via a
cross-reactive immune response of antigen mimicry, which
has also been reported for American trypanosomiasis.17
Autoimmunity that is induced by mechanical antigen
exposure or by cross-reactive antibody production cannot
be distinguished in established usual experimental models
with active or chronic infection because both processes can
occur concomitantly.
To search for anti-retina antibodies that could serve as
markers for eye disease, we investigated the serum levels
of anti-retina antibodies in asymptomatic anti-Toxoplasma
seropositive and seronegative uveitis patients who were
diagnosed with or without ocular toxoplasmosis. Whole
human retina extracts, S-antigens and IRBP were analyzed
using an optimized ELISA.
MATERIALS AND METHODS
Serum samples
Five hundred serum samples were recovered from
storage at the Protozoology Laboratory of IMTSP; these
samples were previously used in epidemiological studies of
the seroprevalence of toxoplasmosis in Sa˜o Paulo State. The
samples had been collected from healthy individuals with
no symptoms at the time of blood collection, and according
to defined patterns for routine ELISA and IFA anti-T. gondii
IgG serology, 250 samples were positive (Tg IgG+ group),
and 250 samples were negative (Tg IgG- group). We
prospectively collected 80 serum samples from patients
who were diagnosed with uveitis and undergoing treatment
at the Uveitis Service in the Department of Ophthalmology
at the Hospital das Clinicas, University of Sa˜o Paulo, School
of Medicine. Thirty uveitis patients were diagnosed with
ocular toxoplasmosis based on a fundoscopy and laboratory
tests (Tg Uveitis), and 50 uveitis patients were diagnosed
with non-infectious, immune-mediated uveitis (non-Tg
Uveitis). The samples comprised blinded sera from patients
with Vogt-Koyanagi-Harada disease (28), Behc¸et’s disease
(19), vitiligo (2) and ankylosing spondylitis(1). All of the
patients were informed about the nature of the study and
consented to participate. This study was approved by the
institutional ethics committee (CAPPesq HCFMUSP) under
protocol no. 961/04.
Retina antigens
Whole human retina extracts (WHREs) were prepared
from discarded, fresh human eyes that were obtained
after corneal removal for transplantation from our hospital
corneal transplant program. The retina was carefully
removed and placed in a 1.5-ml conical tube containing
0.5 ml of sample buffer comprising 0.125 M Tris/HCl,
pH 6.8, 1% sodium dodecyl sulfate, 4 M urea, 1 mM
phenylmethanesulfonyl fluoride, 5 mM EDTA and 1 mg/ml
bromophenol blue. These were stored at -17 C˚ until use. The
extract was prepared as follows: the contents of the tube
were placed in a mortar, frozen with liquid nitrogen, and
ground to a powder with a porcelain pestle. The frozen
powder was returned to the tube, heated to 65 C˚ for
15 minutes and centrifuged at 10,0006g for 2 minutes. The
protein content of the supernatant fraction was measured
using the Bradford assay, adjusted to 250 mg/ml and used
for microplate adsorption. SDS-PAGE was performed and
revealed typical protein bands without degradation (data
not shown). Bovine S-antigen was purified according to the
reported method18, whereas bovine interphotoreceptor
retinoid-binding proteins (IRBPs) were isolated as else-
where reported19 and stored at -70 C˚ until use.
ELISA assays
The population samples were randomly assorted in each
plate. All of the selected samples were tested using an
improved ELISA. Briefly, WHRE, IRBP and S-antigen were
dissolved in 8 M urea at 2 mg protein/ml, and 100 ml/well
were adsorbed overnight at 4 C˚. The plates were washed
and blocked with phosphate-buffered saline containing
0.3% non-fat dry milk and 0.05% Tween-20 (PBST); this
buffer was used for all of the washes and serum or
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conjugate dilutions. After washing and blocking in PBST,
1100 serum dilutions in PBST containing 0.125 M urea were
allowed to react for 2 h at 37 C˚. After additional washes, the
wells were incubated with specific anti-human Fc IgG
conjugates for 1 h at 37 C˚. The wells were washed, and the
bound conjugates were visualized with o-phenylenediamine
(OPD) and hydrogen peroxide. The reaction was stopped
with 4 N HCL, and the optical densities at 492 nm were
determined using a microplate reader. The samples were
considered reactive according to an arbitrary cut-off that was
based on the results of whole group of uveitis patients. The
positive cut-off level was defined using the lower 99%
confidence interval of uveitis samples; data below this level
were considered negative for each specific reaction.
Statistical analysis
Mean antibody levels were compared between the popu-
lations using the Student’s t-test or a one-way ANOVA
following a variance assessment using Bartlett’s test. The
ANOVA was followed by a post-hoc comparison using
Bonferroni’s multiple comparisons test. The results were
also confirmed using the Mann-Whitney or the Kruskal-
Wallis test with Dunnet’s post-tests. The frequency of
positivity and the odds ratio were analyzed using chi-
square tests. The calculated frequencies and means were
considered significantly different when the probability of
equality was less than 5% (p,0.05). All statistical analyses
were performed using GraphPad Prism version 3.00 for
Windows (GraphPad Software, San Diego, California USA,
www.graphpad.com).
RESULTS
Optimized ELISA for the detection of human anti-
retina IgG
We standardized a selective and efficient ELISA for the
detection of anti-retina antibodies using three different
retina antigens, as described in the Methods section. In this
test, there was a low concentration of protein antigens in the
solid phase, and the serum was diluted using a chaotrope-
containing dilution buffer that diminished non-specific
binding. We also used a selective anti-human Fc conjugate,
which provided greater assay efficiency. Eighty uveitis
patient samples were tested in the ELISA, including 30
serum samples from patients with Toxoplasma uveitis, and
the results determined the cut-off of the positive reaction in
each test using the lower 99% confidence interval of all
uveitis samples. Five hundred samples from the adult
asymptomatic population were tested; 250 of these samples
were positive for anti-T. gondii IgG (contact with the infec-
tious agent), and 250 samples were from asymptomatic
patients (no contact with the infectious agent). The results
obtained for each individual assay are presented below.
WHRE ELISA
The distribution of the quantitative results for the WHRE
in each group is presented in Figure 1. The samples from
uveitis patients showed higher levels of anti-WHRE IgG in
comparison to the associated asymptomatic population
(p,0.001). No differences in reactivity were found with
respect to ocular toxoplasmosis or other uveitis etiologies,
which allowed the determination of a cut-off of 0.12 A492nm.
In the asymptomatic groups, the mean level of anti-retina
antibodies in the samples from patients with T. gondii IgG
was higher than that in patients without contact with this
agent, as detected by ANOVA (p,0.05). Using the cut-off
that was determined for the uveitis patients, the qualitative
data revealed a greater number of samples with values
above the cut-off (67/250) in the group with T. gondii IgG
than in that (39/250) without T. gondii contact (p,0.005); the
OR for the association of anti-retina antibodies and anti-T.
gondii IgG in the serum was 1.98 (C.I.95% 1.25 to 3.16).
S-antigen ELISA
The presence of antibodies against bovine S-antigen in
our samples was also tested by ELISA, and the results are
shown in Figure 2. The samples from the uveitis patients
showed higher mean values of anti retina antibodies in
comparison to those determined for the asymptomatic
population. However, some high outliers were detected
using this assay (p,0.001). The cut-off value was 0.089
A492nm, and the difference between the groups was not
significant, which likely reflects the low reactivity to this
antigen. Both asymptomatic populations presented similar
mean levels of anti-retina antibodies and no differences with
respect to the presence of chronic T. gondii infection. Using
the cut-off obtained from the uveitis patients, the frequency
of samples that were positive for S-antigen among the anti-
T. gondii-IgG-positive patients (116/250) was found to be
similar to that in the samples (99/250) from the group
without T. gondii contact.
IRBP ELISA
Antibodies against bovine IRBP antigen were also tested
using the low-protein ELISA, and the results are shown in
Figure 3. This assay showed the lowest level of reactivity,
Figure 1 - Antibody reactivity against whole human retina
extracts (WHRE) as determined using chaotrope in the serum
dilution. Non-Tg uveitis: samples from patients with uveitis other
than toxoplasmosis (n = 50; see Methods). Tg uveitis: Toxoplasma
uveitis samples (n = 30). Tg IgG -: samples from individuals who
were seronegative for T. gondii (n = 250). Tg IgG+: samples from
individuals who were seropositive for T. gondii. Bars represent
mean values. The y-axis was interrupted at cut-off using the
mean minus 2 SD of samples from all uveitis patients.
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but it also demonstrated that the samples from uveitis
patients had higher mean levels of anti-IRBP IgG in
comparison to those from the asymptomatic population
(p,0.001). Toxoplasma uveitis samples presented the highest
mean levels of anti-retina antibodies in comparison to the
other groups, but these levels were highly variable and did
not differ statistically from those determined in non-infectious
uveitis patients. A higher mean level of anti-IRBP IgG was
found in asymptomatic chronic toxoplasmosis samples
compared to asymptomatic Toxoplasma-free patient samples
(p,0.05). The cut-off determination failed to resolve the
asymptomatic populations according to the anti-T. gondii IgG
serology due to a low cut-off of 0.05 A492nm in this assay.
Therefore, a high frequency of positive samples was observed:
216/250 positive samples among the asymptomatic patients
without T. gondii contact and 220/250 positive sample among
the anti-T. gondii IgG-positive patients.
DISCUSSION
Independent of T. gondii infection, we discovered higher
levels of antibodies that were reactive to retina antigens
in the sera from uveitis patients in comparison to stored
samples from asymptomatic individuals,. This result was
observed for each of the three antigens used in the solid-
phase ELISA, but the best discrimination was obtained
using our human whole human retina extract. The extract
from the human retinas comprised several proteins, and the
method used to extract the proteins yielded more antigens
than did techniques employing non-denaturing saline or
detergent solutions as described elsewhere.20 We had pre-
viously performed a WHRE ELISA that demonstrated a
higher reactivity and thresholds in the reaction, which
impeded the qualitative analysis; the addition of urea to
the dilution buffer eliminated the non-specific binding
and provided a clear qualitative discrimination of uveitis
patients(data not shown). The urea-containing sample
buffer used for SDS-PAGE allowed the extraction of
hydrophobic domains of the membrane proteins that are
highly prevalent in the retina, which is composed of several
membrane-associated proteins.21 This method of extract
preparation results in a more sensitive antibody detection in
comparison to the use of the less reactive purified retina
antigens, such as S-antigen and IRBP, which are usually of a
bovine origin. These findings have been described pre-
viously in a study that found that the purified antigens
provided less significant results than did the whole retina in
an intact retina immunofluorescence assay.16 In the present
study, the use of IRBP as an ELISA antigen demonstrated
the least efficiency for anti-retina antibody detection despite
the demonstration of definitive results for the mean sample
reactivity in uveitis patients compared to the asymptomatic
population. This test also revealed a higher mean reactivity
for samples from Toxoplasma-infected asymptomatic indivi-
duals than for those from the non-infected asymptomatic
population; however, the individual discrimination was
poor due to the large numbers of reactive samples. The
S-antigen ELISA demonstrated similar results with clear
differences in the mean values of antibody levels and a good
discrimination of the presence of uveitis; however, the
qualitative results were poor. These data demonstrate that
purified antigens may be less efficient in comparison to
the whole extract for determination of the type of retina
involvement, as described previously.22
Several isolated antigens have been proposed for as
targets of autoimmune eye disease and some of them were
associated to the specific disease.23 Our results demonstrat-
ing a higher resolution for the whole retina extract suggest
Figure 2 - Antibodies against bovine retina S-antigen in selected
patients. Non-Tg uveitis: samples from patients with uveitis other
than toxoplasmosis (n = 50; see Methods). Tg uveitis: samples
from patients with Toxoplasma uveitis (n = 30). Tg IgG-: samples
from patients who were seronegative for T. gondii (n = 250). Tg
IgG+: samples from patients who were seropositive for T. gondii.
Bars represent mean values. The y-axis was interrupted at cut-off
using the mean minus 2 SD of samples from all uveitis patients.
Figure 3 - Antibodies against bovine interphotoreceptor reti-
noid-binding protein (IRBP) antigen in selected patients. Non-Tg
uveitis: samples from patients with uveitis other than toxoplas-
mosis (n = 50; see Methods). Tg uveitis: samples from Toxoplasma
uveitis patients (n = 30). Tg IgG-: samples from patients who were
seronegative for T. gondii (n = 250). Tg IgG+: samples from
patients who were seropositive for T. gondii. Bars represent
mean values. The y-axis was interrupted at cut-off using the
mean minus 2 SD of samples from all uveitis patients.
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that exposure to a variety of T. gondii antibodies may affect
the whole retina through a large spectrum of antigens
instead of a specific antigen, which is observed with other
diseases, such as viral24 or degenerative diseases.25 In
qualitative studies of autoantibodies against the retina using
ELISA, the main challenge is the determination of threshold
values. In the current study, an unusual approach was used.
The samples from uveitis patients served as positive
controls for all of the tested antigens, and inflammation
was assumed to result in a humoral response. Based on
these criteria, our WHRE ELISA revealed a few responders
in the asymptomatic population, which permitted its use as
a screening tool. A similar result was not obtained using
specific antigens, such as S-antigen or IRBP, which demon-
strated higher proportions of positive samples in the
asymptomatic population.
The mechanism responsible for the induction of anti-retina
antibodies is controversial because the eye is a specialized
compartment with respect to the immune response. The eye
is considered a sanctuary compartment in which antigens
evade immune detection and clonal selection until the
protective eye barriers are impaired26 No lymphatic drainage
occurs in the intraocular compartment, which appears to
function similarly to immunologically privileged biological
sites, and therefore, an alteration of immune function and
antigen presentation are observed.27 This phenomenon is
sustained in sympathetic ophthalmia, in which the traumatic
exposure of intraocular components to the immune response
may lead to intraocular inflammation in the non-affected
healthy eye.4 Other examples of autoimmune eye disease
included tissue-specific diseases, such as VKH,28 or systemic
autoimmune diseases, such as Behcet’s disease and systemic
lupus erithemathosus.30
During the first episode of intraocular inflammation
caused by T. gondii, retina antigens are exposed to the
immune response, which leads to the selection of antigen-
specific reactive memory cells both for humoral or cell
mediated immunity. Cyst reactivation or re-infection of the
eye could establish secondary anamnestic and granuloma-
tous responses, which are typical of the adaptive immune
response. This process has been reported using cell
proliferation assays to assess cellular immunity to eye self-
antigens, and the results demonstrated a weak cellular
response to uncontrolled disease.30
The sera of uveitis patients demonstrated higher levels of
anti-retina autoantibodies, regardless of the etiology. Our
screening analysis also revealed higher levels of those
antibodies in samples from the asymptomatic populations
that demonstrated a high titer of anti-retina specific anti-
bodies, and these results could imply the presence of a retinal
disease. This association highlights the importance of the use
of serological surveys to detect anti-retina antibodies in
patients as a screening tool for ophthalmologic consultations,
the selection of patients for follow-up, and early diagnosis and
treatment, especially in patients with serologies that are
positive for Toxoplasma. Our data strongly suggest that the
immune damage caused by Toxoplasma invasion of the retina
results in uveitis both by a direct mechanism and by retina
antigen exposure, as determined by the humoral immune
host response against retina antigens.
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